AIM ImmunoTech Inc.
AIM
$1.47
$0.075.00%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.00% | 56.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.00% | 56.25% | |||
| Cost of Revenue | 580.00% | 0.00% | |||
| Gross Profit | -380.00% | 150.00% | |||
| SG&A Expenses | 20.91% | -43.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.41% | -26.52% | |||
| Operating Income | 7.52% | 26.89% | |||
| Income Before Tax | -17.54% | 24.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.54% | 24.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.54% | 24.59% | |||
| EBIT | 7.52% | 26.89% | |||
| EBITDA | 7.64% | 27.24% | |||
| EPS Basic | 57.37% | 30.84% | |||
| Normalized Basic EPS | 57.25% | 31.56% | |||
| EPS Diluted | 57.37% | 30.84% | |||
| Normalized Diluted EPS | 57.25% | 31.56% | |||
| Average Basic Shares Outstanding | 175.70% | -98.93% | |||
| Average Diluted Shares Outstanding | 175.70% | -98.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||